Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
56.83
+0.08 (0.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $2.98 billion as of December 20, 2024. Its market cap has increased by 586.01% in one year.
Market Cap
2.98B
Enterprise Value
2.35B
1-Year Change
586.01%
Ranking
Category
Stock Price
$56.83
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $2.98B, an increase of 385.95%. That is a compound annual growth rate of 56.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.98B | 502.26% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 3.27B |
| Inari Medical | 3.19B |
| Envista Holdings | 3.10B |
| Denali Therapeutics | 3.09B |
| Veracyte | 3.03B |
| BrightSpring Health Services | 2.97B |
| Xenon Pharmaceuticals | 2.97B |
| Warby Parker | 2.92B |